World News
Regeneron shares fall after FDA rejects high-dose eye disease treatment
[ad_1] A view of the Regeneron Pharmaceuticals headquarters in Tarrytown, New York. Lev Radin | LightRocket | Getty Images Shares of Regeneron fell nearly…
[ad_1] A view of the Regeneron Pharmaceuticals headquarters in Tarrytown, New York. Lev Radin | LightRocket | Getty Images Shares of Regeneron fell nearly…
[ad_1] Want to know why you lost your sense of smell after a COVID-19 infection? A small new study may have the answer. The…